Note: Ingredients listed on restricted chemical lists
General Information
Revision date
2004-12-09
Product name
BREVITAL(R) C-IV (methohexital sodium for injection, USP)
Substance name
BREVITAL(R) C-IV (methohexital sodium for injection, USP)
1.2.1 Relevant identified uses
pharmaceutical
Emergency telephone
NUMBER: 1-800-776-3637
Icons in SDS
Company Information
company name
KING PHARMACEUTICALS, INC
Section 2
NFPA Ratings
SCALE 0-4) HEALTH=1 FIRE=1 REACTIVITY=0 EMERGENCY OVERVIEW: COLOR: white PHYSICAL FORM: crystalline powder ODOR: odorless
Health hazards
central nervous system depression
Physical hazards
Dust/air mixtures may ignite or explode
Potential health effects
INHALATION: SHORT TERM EXPOSURE: irritation LONG TERM EXPOSURE: no information is available SKIN CONTACT: SHORT TERM EXPOSURE: irritation LONG TERM EXPOSURE: irritation EYE CONTACT: SHORT TERM EXPOSURE: irritation, blurred vision LONG TERM EXPOSURE: no information is available INGESTION: SHORT TERM EXPOSURE: nausea, vomiting, constipation, diarrhea, stomach pain, internal bleeding, drowsiness, dizziness, loss of coordination, unconsciousness, coma, dilated pupils, pin-point pupils, difficulty breathing, blood disorders, irregular heartbeat, changes in blood pressure, bluish skin color, changes in body temperature, lung congestion, heart disorders, kidney damage, allergic reactions LONG TERM EXPOSURE: nerve damage, headache, changes in body temperature, blood disorders, internal bleeding, reproductive effects, allergic reactions, skin disorders